tiprankstipranks
Trending News
More News >
Transcat (TRNS)
:TRNS
Advertisement

Transcat (TRNS) AI Stock Analysis

Compare
189 Followers

Top Page

TRNS

Transcat

(NASDAQ:TRNS)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 4o)
Rating:65Neutral
Price Target:
$58.00
▲(4.96% Upside)
Transcat's overall stock score reflects strong financial performance and positive earnings call highlights, tempered by bearish technical indicators and a high valuation. The company's strategic growth initiatives and acquisitions are promising, but profitability pressures and economic uncertainties pose risks.
Positive Factors
Revenue Growth
The 21% increase in revenue demonstrates strong demand and successful strategic initiatives, indicating robust market positioning and growth potential.
Acquisition Success
Successful acquisitions enhance market presence and diversify revenue streams, supporting long-term growth and competitive advantage.
Balance Sheet Strength
A low debt-to-equity ratio indicates a strong balance sheet, providing financial stability and flexibility for future investments and growth.
Negative Factors
Decline in Net Income
The decrease in net income due to higher expenses may impact profitability, highlighting the need for cost management to sustain margins.
Cash Flow Challenges
Declining free cash flow growth can constrain financial flexibility, affecting the company's ability to invest in growth opportunities.
Service Margin Pressure
Pressure on service margins due to lower growth may affect profitability, necessitating strategic adjustments to sustain long-term performance.

Transcat (TRNS) vs. SPDR S&P 500 ETF (SPY)

Transcat Business Overview & Revenue Model

Company DescriptionTranscat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
How the Company Makes MoneyTranscat generates revenue through multiple streams, primarily from the sale of calibration instruments and equipment, calibration services, and related training and consulting. The company earns money by selling a wide range of products from various manufacturers, which are essential for precision measurement and compliance in regulated industries. Additionally, Transcat's calibration services include on-site and in-house calibration of instruments, which provides a recurring revenue stream as clients require ongoing calibration to meet regulatory standards. The company may also benefit from partnerships with leading instrument manufacturers, allowing it to offer exclusive products and services, thereby enhancing its market presence and sales capabilities.

Transcat Earnings Call Summary

Earnings Call Date:Nov 03, 2025
(Q2-2026)
|
% Change Since: |
Next Earnings Date:Feb 02, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong revenue growth, successful acquisitions, and significant gains in the distribution segment. However, these positives were balanced by a decline in net income due to increased expenses and economic uncertainties affecting the service segment.
Q2-2026 Updates
Positive Updates
Significant Revenue Growth
Consolidated revenue increased 21% to $83 million driven by stable calibration revenue, strong performances from recent acquisitions, and growth in the rental channel.
Strong Acquisition Performance
Recent acquisitions, Essco Calibration and Martin Calibration, have shown strong results with both companies experiencing double-digit growth since acquisition.
Distribution Segment Success
Distribution revenue grew 24% due to high demand, especially in the rental channel, with gross margin expanding by 530 basis points.
Adjusted EBITDA Growth
Consolidated adjusted EBITDA increased 37% with 160 basis points of margin expansion.
AI and Technological Investments
Transcat is investing in AI and data management to improve sales, operations, and customer retention.
Negative Updates
Decline in Net Income
Q2 net income decreased by $2 million compared to the prior year, primarily due to higher interest expenses and increased tax rates.
Impact of CEO Succession Costs
Net income was negatively impacted by one-time expenses related to the CEO succession plan and a higher effective income tax rate.
Service Margin Pressure
Service margins continue to be pressured by lower than historic levels of organic growth and lower year-over-year Transcat Solutions revenue.
Economic Uncertainty Impact
Continued economic uncertainty and volatility have led to delays in closing new business and starting new projects.
Company Guidance
During the second quarter of fiscal 2026, Transcat demonstrated robust performance despite economic volatility, with consolidated revenue increasing by 21% to $83 million. The company's strategic focus on organic service growth, strategic acquisitions, and rental channel expansion contributed to a 26% rise in gross profit and a 120 basis point expansion in gross margins. The service segment recorded a 20% revenue increase, marking its 66th consecutive quarter of year-over-year growth, bolstered by strong performances from recent acquisitions like Essco Calibration. Distribution revenue grew by 24%, driven by high demand in the rental channel, which also led to a 530 basis point increase in gross margin. Adjusted EBITDA grew by 37% with a 160 basis point margin expansion, while the company's balance sheet, supported by a new syndicated credit facility, continued to underpin its growth strategies. Looking ahead, Transcat anticipates a return to high single-digit organic service growth, supported by a strong acquisition pipeline and strategic investments in AI and technology.

Transcat Financial Statement Overview

Summary
Transcat demonstrates solid financial performance with consistent revenue growth and strong cash flow generation. However, profitability margins have faced some pressure, and the return on equity has decreased.
Income Statement
75
Positive
Transcat's income statement shows a consistent revenue growth trend, with a TTM revenue growth rate of 4.98%. The gross profit margin has improved over time, reaching 32.45% in the TTM period. However, the net profit margin has decreased to 3.75% from 5.21% in the previous annual report, indicating some pressure on profitability. The EBIT and EBITDA margins have also declined, suggesting increased operational costs or other expenses.
Balance Sheet
70
Positive
The balance sheet reflects a moderate debt-to-equity ratio of 0.49 in the TTM period, which is manageable but has increased from previous periods. The return on equity has decreased to 3.93% in the TTM, indicating a lower return on shareholders' investments. The equity ratio remains stable, showing a solid equity base relative to total assets.
Cash Flow
80
Positive
Transcat's cash flow statement highlights a strong free cash flow growth rate of 28.36% in the TTM period, indicating improved cash generation. The operating cash flow to net income ratio is healthy at 1.13, suggesting efficient cash conversion. The free cash flow to net income ratio is also robust at 0.63, reflecting good cash retention relative to profits.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue304.37M278.42M259.48M230.57M204.96M173.34M
Gross Profit99.79M89.45M83.81M68.36M58.44M46.12M
EBITDA42.68M37.69M33.82M26.86M23.57M18.65M
Net Income13.48M14.52M13.65M10.69M11.38M7.79M
Balance Sheet
Total Assets484.89M385.24M287.55M195.75M177.76M132.12M
Cash, Cash Equivalents and Short-Term Investments5.08M1.52M35.18M1.53M1.40M560.00K
Total Debt143.78M57.73M21.54M64.41M57.65M27.52M
Total Liabilities189.47M98.36M62.38M96.12M91.59M57.04M
Stockholders Equity295.42M286.88M225.17M99.63M86.18M75.08M
Cash Flow
Free Cash Flow25.11M25.79M19.34M7.54M7.47M17.02M
Operating Cash Flow39.70M38.98M32.62M16.95M17.62M23.64M
Investing Cash Flow-167.60M-84.00M-41.67M-18.51M-39.85M-10.15M
Financing Cash Flow109.40M26.86M27.40M876.00K23.69M-12.65M

Transcat Technical Analysis

Technical Analysis Sentiment
Negative
Last Price55.26
Price Trends
50DMA
65.42
Negative
100DMA
72.78
Negative
200DMA
76.54
Negative
Market Momentum
MACD
-3.33
Negative
RSI
38.88
Neutral
STOCH
44.47
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRNS, the sentiment is Negative. The current price of 55.26 is below the 20-day moving average (MA) of 55.30, below the 50-day MA of 65.42, and below the 200-day MA of 76.54, indicating a bearish trend. The MACD of -3.33 indicates Negative momentum. The RSI at 38.88 is Neutral, neither overbought nor oversold. The STOCH value of 44.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TRNS.

Transcat Risk Analysis

Transcat disclosed 34 risk factors in its most recent earnings report. Transcat reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Transcat Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$1.09B16.1922.61%3.66%0.16%2.99%
71
Outperform
$1.51B18.3019.58%12.76%36.11%
65
Neutral
$504.39M44.484.02%11.81%-39.16%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
59
Neutral
$1.27B-1.68%14.46%-588.82%
54
Neutral
$354.66M56.413.77%12.63%-21.23%
51
Neutral
$383.78M-6.08-9.63%-8.92%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TRNS
Transcat
55.26
-50.64
-47.82%
DXPE
DXP Enterprises
99.03
24.79
33.39%
EVI
EVI Industries
21.81
3.05
16.26%
DSGR
Distribution Solutions Group
27.74
-12.01
-30.21%
GIC
Global Industrial Company
28.67
2.07
7.78%
TITN
Titan Machinery
16.57
1.36
8.94%

Transcat Corporate Events

Transcat’s Earnings Call: Growth Amid Challenges
Nov 5, 2025

The recent earnings call for Transcat painted a picture of robust growth tempered by some challenges. The general sentiment was positive, with strong revenue growth and successful acquisitions taking center stage. However, this optimism was slightly offset by a decline in net income due to increased expenses and economic uncertainties impacting the service segment.

Transcat Reports Strong Q2 2026 Financial Growth
Nov 4, 2025

Transcat, Inc. is a prominent provider of calibration, reliability, and maintenance optimization services, primarily serving the life sciences, aerospace, defense, energy, and utilities sectors. The company also operates as a value-added distributor of test and measurement instruments across North America.

Executive/Board ChangesShareholder Meetings
Transcat Announces New Corporate Controller Appointment
Neutral
Sep 11, 2025

Transcat, Inc. has announced the retirement of Scott D. Deverell as corporate controller and principal accounting officer, effective September 10, 2025. Kristina Johnston, who has been with the company since June 2025, will assume the role. Johnston brings extensive experience from her previous roles at Vintage Wine Estates, Inc. and Constellation Brands, Inc. Additionally, at the annual meeting on September 10, 2025, shareholders elected new directors, approved executive compensation measures, and ratified Deloitte & Touche LLP as the independent accounting firm for the fiscal year ending March 28, 2026. The board also decided to hold annual advisory votes on executive compensation.

The most recent analyst rating on (TRNS) stock is a Hold with a $88.00 price target. To see the full list of analyst forecasts on Transcat stock, see the TRNS Stock Forecast page.

Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Transcat Announces CEO Transition Plan
Positive
Aug 25, 2025

On August 21, 2025, Transcat, Inc. announced a transition plan for CEO Lee D. Rudow, who will retire in March 2026 and then serve as a strategic advisor until 2027. The board has initiated a search for a new CEO, and Rudow’s leadership has been credited with significant growth and acquisitions, positioning the company for a strong future. The company has reiterated a positive outlook for fiscal 2026, highlighting recent financial performance and strategic acquisitions, which are expected to enhance market share and drive organic revenue growth.

The most recent analyst rating on (TRNS) stock is a Buy with a $111.00 price target. To see the full list of analyst forecasts on Transcat stock, see the TRNS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 14, 2025